Cargando…

Topical Brimonidine or Intravitreal BDNF, CNTF, or bFGF Protect Cones Against Phototoxicity

PURPOSE: To develop a focal photoreceptor degeneration model by blue light-emitting diode (LED)-induced phototoxicity (LIP) and investigate the protective effects of topical brimonidine (BMD) or intravitreal brain-derived neurotrophic factor (BDNF), ciliary neurotrophic factor (CNTF), or basic fibro...

Descripción completa

Detalles Bibliográficos
Autores principales: Valiente-Soriano, Francisco J., Ortín-Martínez, Arturo, Di Pierdomenico, Johnny, García-Ayuso, Diego, Gallego-Ortega, Alejandro, Miralles de Imperial-Ollero, Juan A., Jiménez-López, Manuel, Villegas-Pérez, María Paz, Wheeler, Larry A., Vidal-Sanz, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Association for Research in Vision and Ophthalmology 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6919195/
https://www.ncbi.nlm.nih.gov/pubmed/31890348
http://dx.doi.org/10.1167/tvst.8.6.36
_version_ 1783480724231290880
author Valiente-Soriano, Francisco J.
Ortín-Martínez, Arturo
Di Pierdomenico, Johnny
García-Ayuso, Diego
Gallego-Ortega, Alejandro
Miralles de Imperial-Ollero, Juan A.
Jiménez-López, Manuel
Villegas-Pérez, María Paz
Wheeler, Larry A.
Vidal-Sanz, Manuel
author_facet Valiente-Soriano, Francisco J.
Ortín-Martínez, Arturo
Di Pierdomenico, Johnny
García-Ayuso, Diego
Gallego-Ortega, Alejandro
Miralles de Imperial-Ollero, Juan A.
Jiménez-López, Manuel
Villegas-Pérez, María Paz
Wheeler, Larry A.
Vidal-Sanz, Manuel
author_sort Valiente-Soriano, Francisco J.
collection PubMed
description PURPOSE: To develop a focal photoreceptor degeneration model by blue light-emitting diode (LED)-induced phototoxicity (LIP) and investigate the protective effects of topical brimonidine (BMD) or intravitreal brain-derived neurotrophic factor (BDNF), ciliary neurotrophic factor (CNTF), or basic fibroblast growth factor (bFGF). METHODS: In anesthetized, dark-adapted, adult female Swiss mice, the left eye was dilated and exposed to blue light (10 seconds, 200 lux). After LIP, full-field electroretinograms (ERG) and spectral-domain optical coherence tomography (SD-OCT) were obtained longitudinally, and reactive-Iba-1(+)monocytic cells, TUNEL(+) cells and S-opsin(+) cone outer segments were examined up to 7 days. Left eyes were treated topically with BMD (1%) or vehicle, before or right after LIP, or intravitreally with BDNF (2.5 μg), CNTF (0.2 μg), bFGF (0.5 μg), or corresponding vehicle right after LIP. At 7 days, S-opsin(+) cone outer segments were counted within predetermined fixed-size areas (PFA) centered on the lesion in both flattened retinas. RESULTS: SD-OCT showed a circular region in the superior-temporal left retina with progressive thinning (207.9 ± 5.6 μm to 160.7 ± 6.8 μm [7 days], n = 8), increasing TUNEL(+) cells (peak at 3 days), decreasing S-opsin(+) cone outer segments, and strong microglia activation. ERGs were normal by 3 days. Total S-opsin(+) cones in the PFA for LIP-treated and fellow-retinas were 2330 ± 262 and 5601 ± 583 (n = 8), respectively. All neuroprotectants (n = 7–11), including topical BMD pre- or post-LIP, or intravitreal BDNF, CNTF, and bFGF, showed significantly greater S-opsin(+) cone survival than their corresponding vehicle-treated groups. CONCLUSIONS: LIP is a reliable, quantifiable focal photoreceptor degeneration model. Topical BMD or intravitreal BDNF, CNTF, or bFGF protect against LIP-induced cone-photoreceptor loss. TRANSLATIONAL RELEVANCE: Topical BMD or intravitreal BDNF, CNTF, or bFGF protect cones against phototoxicity.
format Online
Article
Text
id pubmed-6919195
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher The Association for Research in Vision and Ophthalmology
record_format MEDLINE/PubMed
spelling pubmed-69191952019-12-30 Topical Brimonidine or Intravitreal BDNF, CNTF, or bFGF Protect Cones Against Phototoxicity Valiente-Soriano, Francisco J. Ortín-Martínez, Arturo Di Pierdomenico, Johnny García-Ayuso, Diego Gallego-Ortega, Alejandro Miralles de Imperial-Ollero, Juan A. Jiménez-López, Manuel Villegas-Pérez, María Paz Wheeler, Larry A. Vidal-Sanz, Manuel Transl Vis Sci Technol Articles PURPOSE: To develop a focal photoreceptor degeneration model by blue light-emitting diode (LED)-induced phototoxicity (LIP) and investigate the protective effects of topical brimonidine (BMD) or intravitreal brain-derived neurotrophic factor (BDNF), ciliary neurotrophic factor (CNTF), or basic fibroblast growth factor (bFGF). METHODS: In anesthetized, dark-adapted, adult female Swiss mice, the left eye was dilated and exposed to blue light (10 seconds, 200 lux). After LIP, full-field electroretinograms (ERG) and spectral-domain optical coherence tomography (SD-OCT) were obtained longitudinally, and reactive-Iba-1(+)monocytic cells, TUNEL(+) cells and S-opsin(+) cone outer segments were examined up to 7 days. Left eyes were treated topically with BMD (1%) or vehicle, before or right after LIP, or intravitreally with BDNF (2.5 μg), CNTF (0.2 μg), bFGF (0.5 μg), or corresponding vehicle right after LIP. At 7 days, S-opsin(+) cone outer segments were counted within predetermined fixed-size areas (PFA) centered on the lesion in both flattened retinas. RESULTS: SD-OCT showed a circular region in the superior-temporal left retina with progressive thinning (207.9 ± 5.6 μm to 160.7 ± 6.8 μm [7 days], n = 8), increasing TUNEL(+) cells (peak at 3 days), decreasing S-opsin(+) cone outer segments, and strong microglia activation. ERGs were normal by 3 days. Total S-opsin(+) cones in the PFA for LIP-treated and fellow-retinas were 2330 ± 262 and 5601 ± 583 (n = 8), respectively. All neuroprotectants (n = 7–11), including topical BMD pre- or post-LIP, or intravitreal BDNF, CNTF, and bFGF, showed significantly greater S-opsin(+) cone survival than their corresponding vehicle-treated groups. CONCLUSIONS: LIP is a reliable, quantifiable focal photoreceptor degeneration model. Topical BMD or intravitreal BDNF, CNTF, or bFGF protect against LIP-induced cone-photoreceptor loss. TRANSLATIONAL RELEVANCE: Topical BMD or intravitreal BDNF, CNTF, or bFGF protect cones against phototoxicity. The Association for Research in Vision and Ophthalmology 2019-12-16 /pmc/articles/PMC6919195/ /pubmed/31890348 http://dx.doi.org/10.1167/tvst.8.6.36 Text en Copyright 2019 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
spellingShingle Articles
Valiente-Soriano, Francisco J.
Ortín-Martínez, Arturo
Di Pierdomenico, Johnny
García-Ayuso, Diego
Gallego-Ortega, Alejandro
Miralles de Imperial-Ollero, Juan A.
Jiménez-López, Manuel
Villegas-Pérez, María Paz
Wheeler, Larry A.
Vidal-Sanz, Manuel
Topical Brimonidine or Intravitreal BDNF, CNTF, or bFGF Protect Cones Against Phototoxicity
title Topical Brimonidine or Intravitreal BDNF, CNTF, or bFGF Protect Cones Against Phototoxicity
title_full Topical Brimonidine or Intravitreal BDNF, CNTF, or bFGF Protect Cones Against Phototoxicity
title_fullStr Topical Brimonidine or Intravitreal BDNF, CNTF, or bFGF Protect Cones Against Phototoxicity
title_full_unstemmed Topical Brimonidine or Intravitreal BDNF, CNTF, or bFGF Protect Cones Against Phototoxicity
title_short Topical Brimonidine or Intravitreal BDNF, CNTF, or bFGF Protect Cones Against Phototoxicity
title_sort topical brimonidine or intravitreal bdnf, cntf, or bfgf protect cones against phototoxicity
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6919195/
https://www.ncbi.nlm.nih.gov/pubmed/31890348
http://dx.doi.org/10.1167/tvst.8.6.36
work_keys_str_mv AT valientesorianofranciscoj topicalbrimonidineorintravitrealbdnfcntforbfgfprotectconesagainstphototoxicity
AT ortinmartinezarturo topicalbrimonidineorintravitrealbdnfcntforbfgfprotectconesagainstphototoxicity
AT dipierdomenicojohnny topicalbrimonidineorintravitrealbdnfcntforbfgfprotectconesagainstphototoxicity
AT garciaayusodiego topicalbrimonidineorintravitrealbdnfcntforbfgfprotectconesagainstphototoxicity
AT gallegoortegaalejandro topicalbrimonidineorintravitrealbdnfcntforbfgfprotectconesagainstphototoxicity
AT mirallesdeimperialollerojuana topicalbrimonidineorintravitrealbdnfcntforbfgfprotectconesagainstphototoxicity
AT jimenezlopezmanuel topicalbrimonidineorintravitrealbdnfcntforbfgfprotectconesagainstphototoxicity
AT villegasperezmariapaz topicalbrimonidineorintravitrealbdnfcntforbfgfprotectconesagainstphototoxicity
AT wheelerlarrya topicalbrimonidineorintravitrealbdnfcntforbfgfprotectconesagainstphototoxicity
AT vidalsanzmanuel topicalbrimonidineorintravitrealbdnfcntforbfgfprotectconesagainstphototoxicity